anti-ROR1 CAR T-cell therapy (Unum Therapeutics)

N/A

Report date: 2025/03/18 18:10:01

Base Information

Drug Nameanti-ROR1 CAR T-cell therapy (Unum Therapeutics)

Drug Alias NameN/A

ClassificationBiologics > Protein drugs > Recombinant protein > Fusion proteinCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapy

Mechanisms of ActionInactive tyrosine-protein kinase transmembrane receptor ROR1 modulators

TargetsInactive tyrosine-protein kinase transmembrane receptor ROR1

Therapy Area/IndicationsOvarian NeoplasmsBreast NeoplasmsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesCogent Biosciences Inc

China Registration ClassN/A

Develop Information

Active CompaniesCogent Biosciences Inc

Inactive CompaniesN/A

Active IndicationsOvarian NeoplasmsBreast Neoplasms

Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A